[Federal Register Volume 63, Number 135 (Wednesday, July 15, 1998)]
[Notices]
[Pages 38176-38182]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-18824]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Announcement 98082]


National Minority Organizations Strategies for the Prevention and 
Control of Diabetes, The National Diabetes Education Program; Notice of 
Availability of Fiscal Year 1998 Funds

Introduction

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of funds for fiscal year (FY) 1998 for the award of 
cooperative agreements to national minority organizations (NMOs) for 
National Diabetes Education Program (NDEP) activities related to the 
prevention and control of diabetes within special populations groups 
disproportionately burdened by this chronic disease (i.e. Black or 
African-American, Hispanic or Latinos, Asian, Native Hawaiian or Other 
Pacific Islanders, and American Indian or Alaska Native). These awards 
will assist NMOs to reach their targeted populations with culturally 
and linguistically appropriate NDEP prevention and control messages 
through community-based intervention approaches and delivery channels.
    CDC is committed to achieving the health promotion and disease 
prevention objectives of Healthy People 2000, a national activity to 
reduce morbidity and mortality and to improve the quality of life. This 
announcement is related to the priority area of Diabetes and Chronic 
Disabling Conditions. (To order a copy of Healthy People 2000, see the 
section ``Where To Obtain Additional Information''.)

Authority

    This program is authorized under Sections 301(a) and 317(k)(2) [42 
U.S.C. 241(a) and 247b (k) (2)] of the Public Health Service Act, as 
amended. Applicable program regulations are found in 45 CFR Part 74.

Smoke-Free Workplace

    CDC strongly encourages all grant recipients to provide a smoke-
free workplace and to promote the nonuse of all tobacco products, and 
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in 
certain facilities that receive federal funds in which education, 
library, day care, health care, or early childhood development services 
are provided to children.

[[Page 38177]]

Eligible Applicants

    Eligible applicants are public and private nonprofit, national 
minority organizations that have the ability to reach those special 
populations specified in the Introduction. Eligible applicants must 
meet all the criteria listed below and provide evidence of eligibility 
in a cover letter and supporting documentation attached to their 
application. If the applicants do not meet all the eligibility criteria 
below, the application will be returned and not reviewed.
    A. The applicant organization must have a primary relationship with 
one of the targeted populations. A primary relationship is one in which 
the targeted population is viewed as the most important benefactor or 
constituent of the organization's mission and activities. The 
relationship to the targeted population must be direct (membership or 
service) rather than indirect or secondary (philanthropy or fund-
raising).
    B. The applicant organization must have affiliate offices, 
chapters, or related-membership organizations in more than one State or 
territory. Individual affiliates or chapters of parent organizations 
are not eligible to apply.
    C. The applicant organization must provide a copy of a letter of 
commitment from the organization's President or Executive Director, 
acknowledging their intent to develop a diabetes prevention and control 
policy and plan that will be adopted by the national organization, and 
moved for adoption by affiliates, chapters, and related-membership 
organizations. If a diabetes prevention and control policy and plan 
already exists within the national organization's office, they should 
be submitted in lieu of a letter of commitment.
    D. A private nonprofit organization must include evidence of its 
nonprofit status with the application. Any of the following is 
acceptable evidence.
    1. A reference to the organization's listing in the Internal 
Revenue Service's (IRS) most recent list of tax-exempt organizations 
described in section 501(c)(3) of the IRS Code.
    2. A copy of a currently valid Internal Revenue Service Tax 
exemption certificate.
    3. A statement from a state taxing body, State Attorney General, or 
other appropriate State official certifying that the applicant 
organization has a nonprofit status and that none of the net earnings 
accrue to any private shareholders or individuals.
    4. A certified copy of the organization's certificate of 
incorporation or similar document if it clearly establishes the 
nonprofit status of the organization.
    In addition, to be considered a national minority organization, 
eligible applicants must meet the following criteria:
    1. At least 51 percent of persons on the governing board must be 
members of racial or ethnic minority populations.
    2. The organization must possess a documented history of serving 
racial and ethnic minority populations through its offices, affiliates, 
or participating minority organizations at the national level for at 
least 12 months before submission of the application to CDC.

    Note: Effective January 1, 1996, Public Law 104-65 states that 
an organization described in Section 501(c)(4) of the Internal 
Revenue Code of 1986 which engages in lobbying activities will not 
be eligible for the receipt of federal funds constituting an award, 
grant, cooperative agreement, contract, loan, or any other form.

Availability of Funds

    Approximately $1.5 million is available in FY 98 to fund from five 
to six awards.
    CDC expects to fund one award in each of the following targeted 
populations: Black or African-American, Hispanic or Latinos, Asian, 
Native Hawaiian or Other Pacific Islanders, and American Indian or 
Alaska Native.
    It is expected that the average award will be $300,000, ranging 
from $200,000 to $400,000. It is expected that the awards will begin on 
or about September 30, 1998, and will be made for a 12-month budget 
period within a project period of up to 3 years. Funding estimates may 
vary and are subject to change.
    Continuation awards within the approved project period will be made 
on the basis of satisfactory progress and the availability of funds.
    Funds may not be expended for the purchase or lease of land or 
buildings, construction of facilities, renovation of existing space, or 
the delivery of clinical and therapeutic services. The purchase of 
equipment is discouraged but will be considered for approval if 
justified on the basis of being essential to the program and not 
available from any other source.

Use of Funds

Restrictions on Lobbying

    Applicants should be aware of restrictions on the use of HHS funds 
for lobbying of Federal or State legislative bodies. Under the 
provisions of 31 U.S.C. Section 1352 (which has been in effect since 
December 23, 1989), recipients (and their subtier contractors) are 
prohibited from using appropriated Federal funds (other than profits 
from Federal contract) for lobbying Congress or any Federal agency in 
connection with the award of a particular contract, grants, cooperative 
agreement, or loan. This includes grants/cooperative agreements that, 
in whole or in part, involve conferences for which Federal funds cannot 
be used directly or indirectly to encourage participants to lobby or to 
instruct participants on how to lobby.
    In addition, the FY 1998 Department of Labor, Health and Human 
Services, and Education, and Related Agencies Appropriations Act 
(Public Law 105-78) states in Sec. 503(a) and (b) no part of any 
appropriation contained in this Act shall be used, other than for 
normal and recognized executive-legislative relations, for publicity or 
propaganda purposes, for the preparation, distribution, or use of any 
kit, pamphlet, booklet, publication, radio, television, or video 
presentation designed to support or defeat legislation pending before 
the Congress or any State legislature, except in presentation to the 
Congress or any State legislative body itself. No part of any 
appropriation contained in this Act shall be used to pay the salary or 
expenses of any grant or contract recipient, or agent acting for such 
recipient, related to any activity designed to influence legislation or 
appropriations pending before the Congress or any State legislature.

Background

    Diabetes is a serious and costly public health problem in the 
United States. In 1997, an estimated 15.7 million people (5.9 percent) 
have diabetes and one-third or 5.4 million people are undiagnosed. 
Diabetes contributed to approximately 187,800 deaths in 1995 and it was 
the seventh leading cause of death according to the National Center for 
Health Statistics. Approximately 798,000 new diabetes cases are 
diagnosed annually. The prevalence of diabetes is 8.2 percent, equally 
impacting both males and females. Diabetes disproportionately affects 
those aged 65 years or older. For example, the prevalence of diabetes 
in the general population aged 20 years or older is 8.2 percent; the 
prevalence is 18.4 percent among those aged 65 years or older. The 
population 65 years or older represent 12.8 percent of the U.S. 
population.
    Diabetes is the leading cause of blindness among working-aged 
adults. It is the leading cause of kidney failure requiring dialysis 
and transplantation. Additionally, more than half of lower limb 
amputations occur among people

[[Page 38178]]

with diabetes. Diabetes imposes a tremendous cost with the direct 
medical and indirect costs totaling approximately $92 billion in 1992. 
People with diabetes have a twofold-fourfold increase in cardiovascular 
disease. The incidence of diabetes is expected to rise in the United 
States given the aging of America, increase in minority populations, 
and trends in higher prevalence of obesity.
    The racial and ethnic population in the United States is 
disproportionately affected by diabetes. For instance, the prevalence 
of diabetes among non-Hispanic blacks is 10.8 percent or 38.5 percent 
higher than among non-Hispanic whites (7.8 percent). On average, 
Hispanic/Latinos are nearly twice as likely to have diabetes as non-
Hispanic whites of similar age. Prevalence data for Asian Americans and 
Pacific Islanders are limited, however, selected studies such as the 
King County, Washington study indicate that among second-generation 
Japanese Americans 45 to 74 years of age, 20 percent of the men and 16 
percent of the women had diabetes.
    Strong scientific evidence exists to support secondary and tertiary 
prevention efforts to reduce the medical, social, and economic burden 
of diabetes among all populations. Results of the Diabetes Control and 
Complications Trial (DCCT) clearly showed that persons with Type 1 
diabetes who maintained tight control of their blood glucose levels can 
dramatically reduce their risk for long-term medical complications such 
as blindness, lower limb amputations, and kidney failure. Other studies 
suggest that tight glucose control has similar benefits for persons 
with Type 2 diabetes and reduces the risk for heart attacks, strokes, 
and peripheral vascular diseases. With so much scientific evidence, the 
question now becomes, What could and should be done to improve the 
prognosis for all people with diabetes?
    The answer begins with the recognition that there is a big gap 
between what is known versus current practice in good diabetes care. 
There is a lack of awareness that diabetes is serious, common, costly, 
and controllable; and that prevention and early detection practices may 
prevent or delay the progression of long-term medical complications. 
This gap is especially true among racial and ethnic minority 
populations who have less access to culturally and linguistically 
appropriate diabetes information in the communities where they live. 
The U.S. health care system inadequately provides prevention and early 
detection services to people with diabetes and does not have the 
capacity to address the special needs of racial/ethnic diverse 
populations.
    CDC and the National Institutes of Health (NIH) joined forces in 
1995 to develop a major new initiative, the NDEP. The NDEP is a 
collaborative effort to improve the treatment and outcome for people 
with diabetes, promote early diagnosis, and ultimately, prevent the 
onset of disease. The NDEP will initially focus on secondary and 
tertiary strategies aimed at the prevention, early detection and 
control of medical complications related to diabetes including the 
reduction of risk factors for cardiovascular disease.
    Targeted audiences of the NDEP include the general public, people 
with diabetes and their families, health professionals, and, purchasers 
and payers of health care and policy makers. The goal of the NDEP is to 
reduce morbidity and mortality caused by diabetes and its 
complications. The NDEP objectives are to (1) increase public awareness 
of the seriousness of diabetes, its risk factors, and potential 
strategies for preventing diabetes and its complications; (2) improve 
understanding of diabetes and its control and to promote self-
management behaviors among people with diabetes; (3) improve health 
care providers' understanding of diabetes and its control and to 
promote an integrated approach to care; and, (4) promote health care 
policies and activities that improve quality and access to diabetes 
care.
    The underlying theme of NDEP messages is, ``diabetes is serious, 
common, costly, and controllable.''
    Through a nationwide Partnership Network, diverse public and 
private sector organizations will be brought together to 
collaboratively address the nation's diabetes burden. The NDEP will 
facilitate the coordination of efforts to reduce the burden of diabetes 
from a national perspective. Science-based diabetes messages will be 
developed and delivered using a wide variety of approaches and channels 
that effectively reach targeted audiences. NDEP messages and strategies 
will be integrated into existing systems of diabetes care, education 
programs, and community-based interventions. NDEP partners include 
federal agencies; State and local health departments; multiple 
professional, voluntary health, racial and ethnic minority groups, 
national, academic, community-based, and civic organizations; as well 
as private sector enterprises (e.g., managed care organizations, 
corporations and small businesses, pharmaceutical and diabetes 
equipment companies, national and local media including racial and 
ethnic minority media, and others).
    It is essential to reach racial and ethnic minority populations 
through the NDEP. Creative and nontraditional methods need to be 
employed to accommodate the cultural, language, literacy, 
intergenerational, and other challenges of delivering diabetes messages 
and education programs to these groups. National minority organizations 
have a great depth of cultural understanding and established trust with 
their targeted populations and many who serve them. They have 
established relationships with individuals and organizations at the 
national, State and local levels that are respected by the targeted 
populations. Additionally, they have unique knowledge of how to 
effectively reach the targeted populations with awareness and education 
programs. NMOs are critical partners of the NDEP. It is through them 
and the partnerships formed to extend the reach of the NDEP that an 
impact may be made in reducing the burden of diabetes among racial and 
ethnic minority populations.

Purpose

    The purpose of this announcement is to strengthen the capacity of 
national minority organizations (NMOs) to collaborate with the NDEP to 
reduce the disproportionate burden of diabetes among high-risk 
populations (e.g. Black or African-American, Hispanic or Latinos, 
Asian, Native Hawaiian or Other Pacific Islanders, and American Indian 
or Alaska Native). These awards will assist NMOs to reach their 
targeted populations with culturally and linguistically appropriate 
NDEP prevention and control messages through trusted and valued 
community-based intervention approaches and delivery channels.

Program Requirements

    Program activities should focus on delivering NDEP messages to the 
targeted populations using a variety of culturally valued and effective 
community-based approaches and channels, establishing coalitions and 
partnerships to extend the reach of the NDEP in the targeted 
populations, and strengthening the health care system's capacity to 
competently provide culturally and linguistically appropriate diabetes 
education and support to diverse racial and ethnic minority 
populations. All program activities should support and be consistent 
with the purpose, goal, objectives, partnership guidelines, messages, 
and strategies of the NDEP.

[[Page 38179]]

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under A. 
(Recipient Activities), and CDC will be responsible for conducting 
activities under B. (CDC Activities).

A. Recipient Activities

    1. Required Activities (Select 3 or More) (based on the needs and 
priorities of the targeted populations and adequacy of existing 
diabetes awareness and education activities).
    (a) Identify and replicate effective cultural and linguistically 
appropriate community-based diabetes awareness and education activities 
and programs that are consistent with the NDEP and deliver them through 
trusted and valued channels. Examples: lay health workers or promoters, 
church-based education, or worksite education.
    (b) Develop and carry out creative new community-based intervention 
strategies for the delivery of culturally and linguistically 
appropriate NDEP messages designed to improve the knowledge, attitude, 
skills, and behaviors related to the prevention, early detection, and 
control of diabetes complications. Example: community information and 
diabetes health promotion partnerships with local businesses, health 
care organizations, government health care programs (e.g., Medicare), 
or media outlets that serve the targeted populations.
    (c) Establish community-based diabetes coalitions among 
organizations that serve the targeted population to extend the reach of 
the NDEP in at least 5 geographically distinct communities with a high 
concentration of the targeted population. Geographically distinct 
communities may be located in different States where the targeted 
population resides. Examples: Actively engage coalition members in a 
State and local partnership network to identify community needs and 
resources, incorporate NDEP messages into existing programs, develop 
joint initiatives and otherwise extend the reach of the NDEP.
    (d) Develop and disseminate user friendly, consumer oriented 
inventories of diabetes education and care resources available to the 
targeted population in 5 or more geographically distinct communities 
with a high concentration of the targeted population. Geographically 
distinct communities may be located in different States where the 
targeted population resides. Examples: referral and resource 
directories.
    (e) Establish culturally and linguistically appropriate mechanisms 
to respond to public inquiries regarding diabetes generated by NDEP 
media and other activities. Examples: multi language 1-800 number or 
information service from local multi language health care clinics.
    (f) Identify, evaluate, and recommend existing diabetes awareness & 
education products that are culturally and linguistically appropriate 
for the targeted population, based on current science and consistent 
with the NDEP. Examples: brochures and pamphlets, videos, books, and 
public service announcements.
    (g) Strengthen the capacity of the State/local health care system 
to competently provide culturally and linguistically appropriate 
diabetes information, education and support to the targeted population 
consistent with the NDEP. Examples: provider training on cultural 
sensitivity relative to diabetes or patient advocate and outreach 
program.
    2. Other Required Activities:
    (a) Participate in appropriate NDEP work groups to define the 
characteristics and needs of the targeted population, recommend 
priority activities and delivery strategies, and develop and test 
culturally and linguistically appropriate diabetes messages, 
information and educational products, and guidelines for developing 
community-based programs that reach the targeted population through 
participation on appropriate NDEP work groups.
    (b) Incorporate culturally and linguistically appropriate NDEP 
diabetes prevention and control messages into all proposed program 
activities.
    (c) Establish public and private sector partnerships to extend the 
reach of the NDEP in the targeted population.
    (d) Assess the accomplishment and effectiveness of each program 
objective and major activity following a well-designed evaluation plan.
    (e) Participate in the annual CDC Diabetes Control Conference, 
annual NDEP Partnership Network meeting, and 1-2 NDEP work group 
meetings (as appropriate).
    (f) Identify additional public and private sector resources to 
extend, sustain and expand NDEP program activities initiated under this 
program announcement.
    (g) Disseminate pertinent program information to other CDC-funded 
grantees, NDEP partner organizations, and other appropriate agencies 
and partners at the national, State and local levels.

B. CDC Activities

    1. Provide periodic updates of the nationwide activities and 
progress of the NDEP and an explanation of how they relate to the 
purpose of this award.
    2. Include recipients as participants in NDEP work groups formed to 
develop specific program components that are relevant to the purpose of 
this award.
    3. Provide culturally and linguistically tested NDEP messages, 
information and education products, and guidelines for the development 
of community-based programs that reach the targeted populations as they 
become available for dissemination.
    4. Collaborate with recipients in the development, implementation, 
evaluation, and dissemination of proposed program activities to ensure 
their consistency with the NDEP and provide technical assistance and 
consultation, as needed.
    5. Provide periodic updates about public knowledge, attitudes, 
practices, and effective interventions for the prevention, early 
detection, and control of diabetes, and up-to-date scientific 
information.
    6. Collaborate with recipients in the development of publications, 
manuals, modules, etc. that relate to this award.

Technical Reporting Requirements

    An original and two copies of a quarterly progress report are due 
30 days after the end of each quarter. The progress reports must 
include the following for each program, function, or activity: (1) A 
comparison of actual accomplishments to the objectives established for 
the reporting period; (2) the reasons for slippage if established 
objectives were not met; and (3) other pertinent information.
    An original and two copies of the financial status report (FSR) 
must be submitted no later than 90 days after the end of each budget 
period. A final financial status and performance reports providing an 
overall evaluation of the 3 year program are required no later than 90 
days after the end of the project period. All reports are submitted to 
the Grants Management Branch, Procurement and Grants Office, CDC.

Application Content

    Applicants should focus on reaching the targeted population that 
they have the greatest likelihood of impacting and propose program 
activities that are consistent with the purpose of the award and 
description of recipient activities in this announcement. All program 
activities should support and be consistent with the purpose, goal, 
objectives, partnership guidelines, messages, and strategies of the 
NDEP. The application should be organized and presented following the 
outline described below. Program definitions

[[Page 38180]]

and information that can be helpful in completing the application are 
attached.
    Applicants must develop their applications in accordance with PHS 
Form 5161-1 (OMB Number 0937-0189), information contained in the 
program announcement, and the instructions below. The application 
should be limited, including PHS forms, budget information, and 
appendixes, to no more than 75 single-spaced pages. All materials 
should be suitable for photocopying. The application should not contain 
audiovisual materials, posters, tapes, etc.

A. Background and Need

    1. Describe the targeted population to include the magnitude and 
scope of diabetes, existing activities and programs, barriers and gaps 
in diabetes prevention and control efforts, and need for the proposed 
program activities.
    2. Describe the characteristics of the targeted population relative 
to their racial and ethnic diversity and knowledge, attitudes, beliefs, 
and health practices relative to diabetes.

B. Objectives

    1. Identify the 3-year measurable outcome objectives for the 
program consistent with the purpose of this announcement and recipient 
activities.
    2. Identify the process objectives for each budget year.

C. Program Activities

    1. Clearly describe the specific activities that will be undertaken 
to achieve each of the program's process objectives during the year 01 
budget period consistent with the recipient activities.
    2. Briefly describe the activities planned for budget years 2 and 
3.

D. Capabilities

    1. Describe the organization's mission, structure and function, 
size, national membership, substructure, activities on a regional, 
State, or local level, and methods of routine communication with 
constituents and members (newsletters, journals, meetings, etc.). 
Explain how this infrastructure will be used to support successful 
implementation of the proposed program activities.
    2. Describe the organization's past and present awareness and 
education activities in the prevention, early detection, and control of 
diabetes. Describe the organization's other past and present diabetes 
activities such as diabetes support groups and clinical services. 
Explain how NDEP messages can be integrated and how the proposed 
program activities will expand rather than duplicate present 
activities.
    3. Describe the organization's past and present participation in 
planning or developing the National Diabetes Education Program.
    4. Describe past and present collaborative partnerships with public 
and private sector organizations that serve or have established 
linkages in the targeted population. Include evidence of collaborations 
with partners such as memorandums of agreement. Explain how these 
partnerships can be used to support successful implementation of the 
proposed program activities.
    5. Describe the nature and extent of constituent support for past 
and present organizational activities related to awareness and 
education activities for the prevention and control of diabetes. 
Explain how constituent support will be secured for the proposed 
program activities.

E. Project Management

    1. Submit a work plan that outlines the main implementation steps 
and activities to be completed by specified targeted dates to achieve 
the process objectives for the budget year. Identify the persons or 
positions responsible for carrying out the activities.
    2. Describe each proposed position for this program by job title, 
function, general duties, and the main activities with which that 
position will be involved. Describe the qualifications for the project 
coordinator position in terms of education, experience and desired 
skills. Include the level of effort and allocation of time for each 
project activity by staff position. Minimal staffing should include a 
full-time project coordinator and one program assistant.

F. Program Evaluation Plan

    Identify methods for attaining measurable outcome and process 
objectives, accomplishing program activities, and monitoring program 
quality including the consistency of activities with the NDEP. The 
evaluation plan should include qualitative and quantitative data 
collection and assessment mechanisms. As appropriate, this plan should 
include baseline data for the proposed objectives or the mechanism that 
will be used to establish the baseline data; the minimum data to be 
collected to evaluate the achievement of proposed program objectives; 
and the systems for collecting and analyzing the data. Data to be 
reported will be dependent on the proposed program objectives and 
activities, however, examples of potential data include, but are not 
limited to the following:
    1. The number expected to be reached in the targeted population and 
the plan for evaluating the number actually reached.
    2. Information about the State affiliates, local community-based 
organizations and other partners reached and their activities.
    3. Information about the health organizations and providers reached 
and populations served.
    4. When, where, and how often activities are conducted.
    5. Cultural and linguistically appropriate program products 
developed and disseminated and their consistency with the NDEP.
    6. Information on the change in knowledge, attitudes, and self-
management practices among people with diabetes.
    7. Information on the number of existing programs or organizations 
that have incorporated the NDEP messages and strategies including a 
description of their activities.
    8. Information on the number and types of public and private sector 
partnerships and coalitions established to extend the reach of the NDEP 
including a description of their activities.

G. Budget and Narrative Justification

    Provide a detailed line-item budget and narrative justification for 
all operating expenses consistent with the proposed objectives and 
planned activities. Be precise about the program purpose of each budget 
item and itemize calculations when appropriate.
    Applicants should budget for the following costs: Out-of-State 
Travel: Participation in CDC-sponsored training workshops and meetings 
is essential for the effective implementation of diabetes control 
programs. Travel funds should be budgeted for the following meetings:
    1. Two persons to attend the CDC Diabetes Prevention and Control 
Conference (3 days) held during Spring of 1999.
    2. Two persons to attend the 1999 NDEP Partnership Network Meeting 
in Atlanta, or another specified location (2-3 days).
    3. One person to attend 1-2 NDEP work group meetings related to 
program development during 1999 (2 days each meeting).

H. Attachments

    Provide these attachments:
    1. An organizational chart and 1-page resums of current and 
proposed staff. Include 1 page job descriptions of proposed staff.
    2. A list of applicant's constituents by regional, State, and local 
organization(s).

[[Page 38181]]

    3. Evidence of collaboration with other organizations that serve 
the same targeted populations. Include Memorandums of Agreement and 
letters of support.
    4. A description of funding from other sources to conduct similar 
activities:
    (a) Describe how funds requested under this announcement will be 
used differently or in ways that will expand on the funds already 
received, applied for, or being received.
    (b) Identify proposed personnel devoted to this project who are 
supported by other funding sources and the activities they are 
supporting.
    (c) Written statement that the funds being requested will not 
duplicate or supplant funds received from any other sources.
    5. Proof of eligibility.

Typing and Mailing

    Applicants are required to submit an original and two copies of the 
application. Number all pages clearly and sequentially and include a 
complete table of contents for the application and its appendixes. The 
original and each copy of the application must be submitted unstapled 
and unbound. Print all material, single-spaced, in a 12-point or larger 
font on 8 1/2'' by 11'' paper, with at least 1'' margins and printed on 
one side only. The application length should be no more than 75 pages 
total including appendixes, an itemized budget with justification and 
the required forms.

Evaluation Criteria (100 Points)

    Objective Review panels evaluate the scientific and technical merit 
of applications and their responsiveness to the information requested 
in the ``Application Content'' section above. The application will be 
reviewed and evaluated according to the following criteria:

A. Background and Need (10 Points)

    The extent to which the applicant demonstrates an understanding of 
the program's purpose and objectives, describes the characteristics, 
diabetes burden and needs of the targeted population, and justify the 
need for the proposed activities.

B. Objectives (15 Points)

    The extent to which the proposed outcome and process objectives are 
specific, time-related, measurable, appropriate for the targeted 
audience, and consistent with the stated purpose of this announcement.

C. Program Activities (25 Points)

    The appropriateness of the proposed program activities for the 
targeted population, likelihood that they are achievable, and 
expectation that their implementation will lead to accomplishment of 
the proposed process and outcome objectives within the project period.

D. Capabilities (20 Points)

    1. The capacity of the applicant's infrastructure in supporting 
successful implementation of the proposed program activities in the 
targeted population.
    2. The success of the applicant's past and present experiences in 
working with the targeted population, conducting diabetes awareness and 
education activities, collaborating with public and private sector 
partners and the potential contribution of these experiences to the 
success of the proposed program activities.
    3. The success of the applicant in generating constituent support 
for past and present organizational activities and the likelihood that 
strong support can be secured for the proposed program activities.

E. Project Management (20 Points)

    1. The adequacy of the work plan in outlining the main program 
implementation steps with time lines and identification of appropriate 
responsible positions or persons.
    2. The adequacy of proposed personnel time allocations and the 
extent to which proposed staff exhibit appropriate qualifications and 
experience to accomplish the program activities.

F. Program Evaluation Plan (10 Points)

    The appropriateness and quality of the evaluation plan for 
monitoring the program's progress, quality and accomplishments relative 
to the achieving the outcome and process objectives and completing the 
proposed program activities.

G. Budget and Justification (Not Weighted)

    The extent to which the budget is reasonable and consistent with 
the purpose and objectives of the cooperative agreement.

Content of Noncompeting Continuation Applications

    In compliance with 45 CFR 74.51(d), noncompeting continuation 
applications submitted within the project period need only include:
    A. A brief progress analysis that describes the accomplishments 
from the start of the project period.
    B. Any new or significantly revised items or information 
(objectives, scope of activities, operational methods, evaluation, 
etc.) not included in the year 01 application.
    C. An annual budget and justification. Existing budget items that 
are unchanged from the previous budget period do not need 
rejustification. Simply list the items in the budget and indicate that 
they are continuation items. Supporting justification should be 
provided where appropriate.

Executive Order 12372 Review

    Applications are not subject to Executive Order 12372, 
Intergovernmental Review of Federal Programs.

Public Health System Reporting Requirements

    This program is subject to the Public Health System Reporting 
Requirements.

Catalog of Federal Domestic Assistance Number

    The Catalog of Federal Domestic Assistance number is 93.283.

Other Requirements

Paperwork Reduction Act

    Projects that involve the collection of information from 10 
individuals or more and funded by the cooperative agreement will be 
subject to review by the Office of Management and Budget (OMB) under 
the Paperwork Reduction Act.

Human Subjects Requirements

    If a project involves research on human subjects, assurance (in 
accordance with Department of Health and Human Services Regulations, 45 
CFR Part 46) of the protection of human subjects is required. In 
addition to other applicable committees, Indian Health Service (IHS) 
institutional review committees also must review the project if any 
component of IHS will be involved with or will support the research. If 
any American Indian community is involved, its tribal government must 
also approve that portion of the project applicable to it. Unless the 
grantee holds a Multiple Project Assurance, a Single Project Assurance 
is required, as well as an assurance for each subcontractor or 
cooperating institution that has immediate responsibility for human 
subjects. The Office for Protection from Research Risks (OPRR) at the 
National Institutes of Health (NIH) negotiates assurances for all 
activities involving human subjects that are supported by the 
Department of Health and Human Services.

[[Page 38182]]

Inclusion of Women and Racial and Ethnic Minorities in Research

    It is the policy of the Centers for Disease Control and Prevention 
(CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR) 
to ensure that individuals of both sexes and the various racial and 
ethnic groups will be included in CDC/ATSDR-supported research projects 
involving human subjects, whenever feasible and appropriate. Racial and 
ethnic groups are those defined in OMB Directive No. 15 and include 
American Indian or Alaska Native, Asian, Black or African American, 
Hispanic or Latino, Native Hawaiian or Other Pacific Islander. 
Applicants shall ensure that women, racial and ethnic minority 
populations are appropriately represented in applications for research 
involving human subjects. Where clear and compelling rationale exist 
that inclusion is inappropriate or not feasible, this situation must be 
explained as part of the application. This policy does not apply to 
research studies when the investigator cannot control the race, 
ethnicity, and/or sex of subjects. Further guidance to this policy is 
contained in the Federal Register, Vol. 60, No. 179, pages 47947-47951, 
and dated Friday, September 15, 1995.

Application Submission and Deadline

    The original and two copies of the application PHS Form 5161-1 
(Revised 5/96, OMB Number 0937-0189) must be submitted to Sharron P. 
Orum, Grants Management Officer, Procurement and Grants Office, Centers 
for Disease Control and Prevention (CDC), Room 300, Mail Stop E-18, 255 
East Paces Ferry Road, NE., Atlanta, GA 30305, on or before August 15, 
1998.
    1. Deadline: Applications shall be considered as meeting the 
deadline if they are either:
    (a) Received on or before the deadline date; and
    (b) Sent on or before the deadline date and received in time for 
submission to the objective review group. (Applicants must request a 
legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or U.S. Postal Service. Private 
metered postmarks will not be accepted as proof of timely mailing.)
    2. Late Applications: Applications that do not meet the criteria in 
1.(a) and 1.(b) above are considered late applications. Late 
applications will not be considered in the current competition and will 
be returned to the applicant.

Where to Obtain Additional Information

    A complete program description and information on application 
procedures may be obtained in an application package. Business 
management technical assistance may be obtained from Sharron Orum, 
Grants Management Officer, Grants Management Branch, Procurement and 
Grants Office, Centers for Disease Control and Prevention (CDC), Room 
314, Mail Stop E-18, 255 East Paces Ferry Road, NE., Atlanta, GA 30305; 
telephone (404) 842-6508 or the Internet at, <a href="/cdn-cgi/l/email-protection#1b687773285b787f78357c746d"><span class="__cf_email__" data-cfemail="94e7f8fca7d4f7f0f7baf3fbe2">[email protected]</span></a>. Programmatic 
technical assistance may be obtained from Rita Diaz-Kenney, Division of 
Diabetes Translation, National Center for Chronic Disease Prevention 
and Health Promotion, Centers for Disease Control and Prevention (CDC), 
Mail Stop K-10, 4770 Buford Highway NE., Atlanta, GA 30341-3724; 
telephone (770) 488-5016, or the Internet at: <a href="/cdn-cgi/l/email-protection#3143475500715255521f565e47"><span class="__cf_email__" data-cfemail="5220243663123136317c353d24">[email protected]</span></a>.
    You may also obtain this announcement, and other CDC announcements, 
from one of two Internet sites on the actual publication date: CDC's 
home-page at http://www.cdc.gov or the Government Printing Office home-
page (including free on-line access to the Federal Register at <a href="http://
www.access.gpo.gov">http://
www.access.gpo.gov</a>).
    Please refer to Announcement number 98082 when requesting 
information and submitting an application.
    Potential applicants may obtain a copy of Healthy People 2000 (Full 
Report; stock No. 017-001-00474-0) or Healthy People 2000 (Summary 
Report; stock No. 017-001-00473-1) referenced in the Introduction 
through the Superintendent of Documents, Government Printing Office, 
Washington, DC 20402-9325; telephone (202) 512-1800.

    Dated: July 9, 1998.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 98-18824 Filed 7-14-98; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>